Blackstone BXSL Q1 2026 Earnings Surprise EPS 077 Up Significant Marathon Petroleum Analyst Sentiment Split on Refining Giants Prospects Pharvaris NV PHVS Delivers Q1 2026 Beat EPS 059 vs 073 Expected QXO QXO Q1 2026 Earnings Miss by Significant Key Takeaways Yardeni Suggests Fed Could Raise Rates in July to Counter Bond Vigilantes Amid Warsh Transition Trump Files 10 Billion Defamation Lawsuit Against Wall Street Journal Over Epstein Report Paramount Global Shifts LateNight Strategy What The Late Show Cancellation Means for CBS AEW Double or Nothing 2026 Match Card Streaming Details and Event Strategy for May 24 PayPerView US Treasury Begins Nationwide Rollout of Trump Accounts Mobile Application Sacheerome Limited SME IPO Delivers 218 Returns as Company Reports Strong FY26 Results JOE Q1 2026 Earnings Profitability Maintained on Modest EPS Stock Edges Higher HTO Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher SLXN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline PCG Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gains Tesla Q1 2026 Earnings EPS Beats Estimates as Margins Hold Steady Post Holdings Q1 2026 Earnings Strong EPS Beat Amid Unclear Revenue Picture Skillz Inc SKLZ Gains Over 6 as Stock Nears Key Resistance at 957 InspireMD NSPR Slides 79 as Stock Tests Key Support Near 084 Criteo CRTO Surges 46 Breaking Above Key Resistance Levels Halozyme Therapeutics HALO Rises Modestly Support and Resistance Levels in Focus AN2 Therapeutics ANTX Slips Amid Biotech Sector Headwinds Key Support Levels in Focus Nvidias Earnings Reveal 200 Billion Opportunity and Edge Computing Focus Amid China Market Concession Sangoma Technologies Q1 2026 Earnings EPS Miss Weighs on Shares as Losses Widen NuCana NCNA Nears Support as Shares Edge Lower on Light Trading AN2 Therapeutics ANTX Eases 21 Testing Key Support Near 440 Grupo Aeromexico AERO Edges Higher as Airline Sector Stabilizes Australian Oilseeds Holdings COOT Climbs 489 as Stock Approaches Key Resistance Level enVVeno Medical NVNO Edges Higher Analyzing Recent Price Action and Key Levels Namib Minerals NAMM Surges 438 Testing Key Resistance at 15 Neumora Therapeutics NMRA Stock Holds Steady at 185 as Key Support and Resistance Levels Tighten Verra Mobility VRRM Climbs 09 as Stock Tests Resistance Near 1416